Tag: Biotronik

BIOTRONIK Receives FDA Approval For Next-Generation Family of Pacemakers

The Amvia Edge pacemaker platform introduces always-on, automatic MR detection algorithm to fully streamline MRI workflow LAKE OSWEGO, Ore., July 6, 2023 /PRNewswire/ — BIOTRONIK today announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronization therapy pacemaker […]

Philips and BIOTRONIK expand care for out-of-hospital cardiology labs with new strategic alliance

Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of BIOTRONIK’s cardiovascular technologies and products to the Philips SymphonySuite device programs expands […]

BIOTRONIK ANNOUNCED FIRST IMPLANT OF NEW IMPLANTABLE CARDIAC MONITOR WITH ARTIFICIAL INTELLIGENCE, TARGETING EFFICIENCY IN MONITORING FOR CARDIAC ARRHYTHMIAS

Montefiore Medical Center in New York performed the first global implantation of the new BIOMONITOR IV ICM LAKE OSWEGO, Ore., June 12, 2023 /PRNewswire/ — BIOTRONIK, a leader in implantable medical device technology, today announced the first global implantation of its BIOMONITOR IV implantable cardiac […]

BIOTRONIK Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions

Designed to Leverage AI Technology to Improve the Delivery of Connected Care in Cardiac Diagnostics and Remote Patient Monitoring LAKE OSWEGO, Ore., Sept. 8, 2022 /PRNewswire/ — BIOTRONIK announced today its partnership with AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services. […]

First and Only Peripheral Tri-axial 4-French Low-Profile Self-Expanding Stent System Receives FDA Approval

BIOTRONIK Launches its Pulsar-18 T3 Self-Expanding Stent System in the U.S. LAKE OSWEGO, Ore., July 26, 2022 /PRNewswire/ — BIOTRONIK, LAKE OSWEGO, USA, announced that it received U.S. Food and Drug Administration (FDA) approval of its innovative Pulsar®-18 T3 peripheral self-expanding stent system for an improved implantation procedure for […]

BIOTRONIK’s State-of-the-Art LiveSupport Successfully Used in BIOMONITOR Implantable Cardiac Monitor Implants

LAKE OSWEGO, Ore., July 6, 2022 /PRNewswire/ — BIOTRONIK’s state-of-the-art LiveSupport feature was used to remotely support two BIOMONITOR Implantable Cardiac Monitor (ICM) implants shortly after launch. Both procedures were performed with a BIOTRONIK representative in a remote location. The physicians are […]